Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPDLP2 (HNRNPDL pseudogene 2) is a genomic locus closely related to the gene encoding heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL), a member of the hnRNP family involved in mRNA processing and regulation[2]. Unlike HNRNPDL, HNRNPDLP2 is a pseudogene and does not encode a functional protein. Pseudogenes may arise from gene duplication or retrotransposition events and may serve as evolutionary markers, potential regulators through noncoding RNA mechanisms, or remain functionally silent. There is no evidence that HNRNPDLP2 participates in biological pathways, disease processes, or drug interactions. For functional and therapeutic contexts, HNRNPDL (not HNRNPDLP2) is of interest, particularly in transcriptional regulation and association with certain muscular dystrophies[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HNRNPDL pseudogene 2 (HNRNPDLP2).